Egyptian International Pharmaceutical Industries Company (EGX:PHAR)
Egypt · Delayed Price · Currency is EGP 62.00
+2.70 (4.55%)
At close: Sep 10, 2025
EGX:PHAR Revenue
Egyptian International Pharmaceutical Industries Company had revenue of 2.31B EGP in the quarter ending June 30, 2025, with 22.98% growth. This brings the company's revenue in the last twelve months to 8.82B, up 39.02% year-over-year. In the year 2024, Egyptian International Pharmaceutical Industries Company had annual revenue of 7.59B with 45.09% growth.
Revenue (ttm)
8.82B
Revenue Growth
+39.02%
P/S Ratio
1.19
Revenue / Employee
n/a
Employees
n/a
Market Cap
10.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.59B | 2.36B | 45.09% |
| Dec 31, 2023 | 5.23B | 1.28B | 32.27% |
| Dec 31, 2022 | 3.96B | 546.35M | 16.03% |
| Dec 31, 2021 | 3.41B | 523.18M | 18.13% |
| Dec 31, 2020 | 2.89B | -525.41M | -15.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition